Inogen, Inc.

NASDAQ:INGN

Medical - Devices

Healthcare
$5.42 +0.71%

+$0.05 today

Market cap
$140.93M
Beta
1.60
P/E (TTM)
-7.0
EPS (TTM)
-$0.91
52W Low $5.34High $9.13

Volume 0.22M

Average 0.33M

Balance Sheet

Inspect the capital base behind the business.

Assets

$298.63M

FY 2025 · Annual

+0.8% YoY

Liabilities

$106.39M

FY 2025 · Annual

-13.0% YoY

Equity

$192.23M

FY 2025 · Annual

+10.6% YoY

Balance Sheet

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Cash & Equivalents235.52M187.01M125.49M113.8M103.73M
Short-term Investments9.99M02.98M015.85M
Net Receivables25.8M64.35M42.91M30.1M38.86M
Inventory31.87M34.09M21.84M24.81M25.97M
Other Current Assets019.19M13.85M16.74M13.89M
Total Current Assets329.19M304.65M207.07M185.45M198.3M
Property, Plant & Equipment (Net)63.84M64.92M70.65M62.7M52.86M
Goodwill32.98M32.85M10.06M9.47M10.7M
Intangible Assets60.15M177K34.59M30.49M30.76M
Long-term Investments00000
Tax Assets00000
Other Non-current Assets3.36M2.45M3.83M8.08M6M
Total Non-current Assets160.33M100.4M119.13M110.73M100.33M
Total Assets489.51M405.04M326.19M296.19M298.63M
Account Payables10.26M18.24M13.45M16.62M20.26M
Short-term Debt00000
Tax Payables561K492K27K142K183K
Deferred Revenue8.57M8.88M7.98M6.65M5.5M
Other Current Liabilities6.48M7.79M19.63M22.74M10.12M
Total Current Liabilities61.51M65.35M72.5M76.69M63.54M
Long-term Debt00000
Deferred Tax Liabilities008.54M6.95M6.75M
Deferred Revenue (Non-current)11.86M10.4M8.23M5.75M3.6M
Other Non-current Liabilities22.63M12.12M13.85M16.35M18.19M
Total Non-current Liabilities57.77M42.29M48.89M45.64M42.86M
Total Liabilities119.29M107.64M121.38M122.33M106.39M
Common Stock23K23K23K24K27K
Retained Earnings69.27M(14.5M)(116.95M)(152.84M)(175.58M)
Accumulated OCI1.47M(243K)1.23M(1.5M)4.24M
Other Stockholders Equity00000
Minority Interest00000
Total Equity370.23M297.41M204.81M173.86M192.23M
Total Debt26.67M23.28M21.92M19.41M17.48M
Net Debt(208.85M)(163.74M)(103.57M)(94.39M)(86.25M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$94.4M
Short-term Investments$17.1M
Receivables$41.9M
Inventory$25.0M
Other Current$12.3M
Total Current Assets$190.7M
PP&E (Net)$49.4M
Goodwill$10.5M
Intangible Assets$28.9M
Other Non-current$6.5M
Total Non-current Assets$95.3M
Total Assets$285.9M

Analysis

Selected assets total $285.9M for Latest. The largest visible component is Cash & Equivalents at $94.4M, about 33.0% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 9, 2026
8-KCurrent reportNov 5, 2026
8-KCurrent reportSep 30, 2026
4Statement of changes in beneficial ownershipSep 3, 2026
4Statement of changes in beneficial ownershipSep 3, 2026

How much cash does INGN have?

Inogen, Inc. (INGN) reported $103.73M in cash and equivalents in fiscal 2025.

How much debt does INGN carry?

Inogen, Inc. (INGN) reported $17.48M of total debt, with net debt of -$86.25M.